Prostate News Archive
01-Aug-2007
Walk organizers hope to raise prostate cancer awareness (Hazelwood-Bridgeton Journal)
The 100 Black Men of Metropolitan St. Louis wants to create awareness among black males about the dangers of prostate cancer. OncoGenex and Isis Report Encouraging Interim Phase II Data in Advanced Prostate Cancer, Affirm Phase III Clinical ... (PR Newswire via Yahoo! Finance)
OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. today announced encouraging preliminary data from an ongoing Phase II clinical trial of OGX-011 in combination with second-line chemotherapy in patients with metastatic hormone refractory prostate cancer . Boston Scientific Purchases Prostate Treatment Technology from Celsion Corporation (ThomasNet)
Deal Follows Successful Four-Year Exclusive Distribution of ProlieveŽ Thermodilatation System NATICK, Mass., June 21 - Boston Scientific Corporation (NYSE:BSX) today announced that it has purchased technology for treating symptomatic benign prostatic hyperplasia (BPH, often referred to as enlarged prostate) from Celsion Corporation (AMEX:CLN), following approval of the acquisition by Celsion ... D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame (PR Newswire via Yahoo! Finance)
Many in the prostate cancer community are still outraged over the FDA's decision to deny approval for the immunotherapy drug Provenge. Some have even gone as far as to make threats against Howard I. Clarient Licenses HDC's Prostate Cancer Marker for Dx Commercialization (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
Back to Prostate News Archive
